Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Net Margin (2016 - 2025)

Historic Net Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 33.59%.

  • Ekso Bionics Holdings' Net Margin rose 165900.0% to 33.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 83.97%, marking a year-over-year decrease of 210200.0%. This contributed to the annual value of 63.21% for FY2024, which is 199400.0% up from last year.
  • Ekso Bionics Holdings' Net Margin amounted to 33.59% in Q3 2025, which was up 165900.0% from 196.4% recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Net Margin high stood at 33.59% for Q3 2025, and its period low was 196.4% during Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' median Net Margin value was 92.26% (recorded in 2021), while the average stood at 103.26%.
  • Its Net Margin has fluctuated over the past 5 years, first surged by 1635200bps in 2021, then plummeted by -1475900bps in 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Net Margin (Quarter) stood at 112.56% in 2021, then decreased by -13bps to 126.78% in 2022, then skyrocketed by 48bps to 66.31% in 2023, then decreased by -1bps to 67.05% in 2024, then soared by 50bps to 33.59% in 2025.
  • Its Net Margin stands at 33.59% for Q3 2025, versus 196.4% for Q2 2025 and 104.06% for Q1 2025.